ALEXANDRIA, Va., March 12 -- United States Patent no. 12,247,032, issued on March 11, was assigned to Genentech Inc. (South San Francisco, Calif.).
"Substituted pyrazolo[1,5-apyrimidines as inhibitors of JAK kinases" was invented by Mark Edward Zak (Davidsonville, Md.), Naomi S. Rajapaksa (San Mateo, Calif.), Yun-Xing Cheng (Beijing), Jessica Grandner (San Mateo, Calif.), Daniel G. M. Shore (Redwood City, Calif.), F. Anthony Romero (Redwood City, Calif.) and Marian C. Bryan (Fort Washington, Pa.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds of formula (I)wherein R1, R2, R3, R4, R5 and R6 are as defined herein, and salts thereof, that are useful as JAK kinase inhibitors are described herein. Also p...